Astrovirus Infections

Astrovirus infections, stemming from the Astroviridae family, pose a significant health concern characterized by a non-enveloped, icosahedral structure and a positive-sense, single-stranded RNA genome. The viral genome, featuring three open reading frames (ORFs), particularly ORF2, encodes the capsid protein responsible for host cell recognition and immune response modulation. Replication primarily occurs in gastrointestinal epithelial cells, leading to the disruption of the intestinal barrier and subsequent gastroenteritis. Crucial for developing targeted therapeutic interventions is a deep understanding of the molecular mechanisms underlying astrovirus pathogenesis. The virus employs strategies to evade the host immune response, modulating cytokine production and interfering with antiviral defense mechanisms. The genetic diversity of astroviruses, coupled with the emergence of new strains, contributes to their continuous evolution. Ongoing research efforts focus on elucidating molecular interactions between astroviruses and host cells, identifying potential drug targets, and developing antiviral strategies. In the realm of prevention, vaccination against astroviruses is an active area of investigation, aiming to develop effective measures to reduce the burden of gastroenteritis caused by these viruses. Molecular insights into astrovirus biology not only advance diagnostics and treatment but also contribute to the development of vaccines, enhancing our ability to manage and control astrovirus infections in both human and animal populations.